Skip to main content
Clinical Trials/NCT04256668
NCT04256668
Completed
Not Applicable

Identification and Characterization of Human Sperm Variation and Its Role in Embryonic Development.

University Hospital, Basel, Switzerland1 site in 1 country60 target enrollmentApril 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Male Infertility
Sponsor
University Hospital, Basel, Switzerland
Enrollment
60
Locations
1
Primary Endpoint
Differences in chromatin density.
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

A total of 60 men (40 with a history of infertility and treatment with assisted reproduction and 20 infertile controls achieving conception naturally) will be asked to provide at least one semen sample each for conventional semen analysis including measurement of DNA-fragmentation and semen preparation with swim-up. The prepared semen sample will then analyzed by comprehensive microscopy analyses aiming at identifying distinct subpopulations of spermatozoa based on chromatin density and composition, mitochondrial and acrosome function and epigenetic markers. In addition, spermatozoa samples of selected individuals will be subjected to comprehensive analyses of the chromatin and RNA expression status using epigenomic approaches.

Detailed Description

Hitherto male infertility has been defined by conventional semen analysis only, which mainly consists of determining concentration, progressive mobility and morphology of spermatozoa. However, the diagnostic accuracy of conventional semen analysis is poor and has very limited relationship with the outcome of assisted reproductive medicine. Preliminary data suggest that differences in chromatin density and epigenetic status of sperm may be more relevant, in particular with respect to the growth and differentiation of early embryos. Chromatin density, morphology, mitochondrial status and epigenetic state in sperm of infertile men with disturbances of early embryo development in vitro will be compared with those of infertile men with normal embryo development and with fertile controls. Primary outcome: Features of chromatin density will be determined through staining of large numbers of spermatozoa. Differences in the staining results will be compared with known fertility outcome. Secondary outcome: Development of significant staining parameters towards the selection against sperm with reduced embryonic competence and/or in favor of sperm supporting embryonic development after assisted reproduction, thereby using flow cytometry and sorting (FACS) .

Registry
clinicaltrials.gov
Start Date
April 1, 2020
End Date
February 29, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Men with a history of infertility. Sperm concentration must be \>15 millions per ml.

Exclusion Criteria

  • No vulnerable persons will be invited to participate.

Outcomes

Primary Outcomes

Differences in chromatin density.

Time Frame: 12 months

Staining of the nucleus of spermatozoa with the fluorescent dye chromomycin

Secondary Outcomes

  • Normal and abnormal embryo development after assisted reproduction.(24 months)

Study Sites (1)

Loading locations...

Similar Trials